NUZYRA is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Paratek Pharmaceuticals, Inc.. The primary component is Omadacycline.
Product ID | 71715-001_3d8a724a-2af8-402b-abf5-5844e7bdaf2b |
NDC | 71715-001 |
Product Type | Human Prescription Drug |
Proprietary Name | NUZYRA |
Generic Name | Omadacycline |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2019-02-01 |
Marketing Category | NDA / NDA |
Application Number | NDA209817 |
Labeler Name | Paratek Pharmaceuticals, Inc. |
Substance Name | OMADACYCLINE |
Active Ingredient Strength | 100 mg/5mL |
Pharm Classes | Tetracycline-class Antibacterial [EPC],Tetracyclines [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2019-02-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA209817 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-02-01 |
Marketing Category | NDA |
Application Number | NDA209817 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-02-01 |
Ingredient | Strength |
---|---|
OMADACYCLINE | 100 mg/5mL |
SPL SET ID: | 51591524-4703-44c6-8bde-dce3e6a463d1 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
71715-001 | NUZYRA | omadacycline |
71715-002 | NUZYRA | omadacycline |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
NUZYRA 88438211 not registered Live/Pending |
Paratek Pharmaceuticals, Inc. 2019-05-20 |
NUZYRA 87908478 5741452 Live/Registered |
Paratek Pharmaceuticals, Inc. 2018-05-04 |